Interstitial lung disease and lung transplantation

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 2, 2010, Pages 139-146

  O'Beirne, Sarah ^a,b   Counihan, Ian P ^a,b   Keane, Michael P ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Fibrosis; Lung; Transplant

Indexed keywords

BIOLOGICAL MARKER;

BRONCHIOLITIS OBLITERANS; FIBROSING ALVEOLITIS; GRAFT DYSFUNCTION; HUMAN; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MORTALITY; PATIENT SELECTION; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SURGICAL TECHNIQUE; WALKING;

BIOLOGICAL MARKERS; HEALTH CARE RATIONING; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; PATIENT SELECTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; WAITING LISTS;

EID: 77950527404     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1249110     Document Type: Review

References (55)

1. Table 12.4a Transplant Recipient Characteristics, 1998 to 2007 Recipients of Deceased Donor Lungs. 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 19982007. In: Organ Procurement and Transplantation Network; 2008 http://optn.transplant.hrsa.gov/ar2008/Chapter-VI-AR-CD.htm?cp=7#14
2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002 165 (2) 277-304
3. Bjoraker J A., Ryu J H., Edwin M K. et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998 157 199-203
4. du Bois R, King T E. Jr. Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate. Thorax 2007 62 1008-1012
5. Thabut G, Mal H, Castier Y et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003 126 469-475
6. Chen H, Shiboski S C., Golden J A. et al. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med 2009 180 468-474
7. Haider Y, Yonan N, Mogulkoc N, Carroll K B., Egan J J. Bronchiolitis obliterans syndrome in single lung transplant recipientspatients with emphysema versus patients with idiopathic pulmonary fibrosis. J Heart Lung Transplant 2002 21 327-333
8. Orens J B., Estenne M, Arcasoy S et al, Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 updatea consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006 25 745-755
9. Collard H R., King T E. Jr, Bartelson B B., Vourlekis J S., Schwarz M I., Brown K K. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003 168 538-542
10. Flaherty K R., Mumford J A., Murray S et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003 168 543-548 (Pubitemid 37088596)
11. King T E. Jr, Safrin S, Starko K M. et al. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest 2005 127 171-177
12. Lederer D J., Arcasoy S M., Wilt J S., D'Ovidio F, Sonett J R., Kawut S M. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006 174 659-664
13. Lama V N., Flaherty K R., Toews G B. et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003 168 1084-1090
14. Boon K, Bailey N W., Yang J et al. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One 2009 4 e5134
15. Rosas I O., Richards T J., Konishi K et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008 5 e93
16. Prasse A, Probst C, Bargagli E et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009 179 717-723
17. Kinder B W., Brown K K., McCormack F X. et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009 135 1557-1563
18. Meyers B F., Lynch J P., Trulock E P., Guthrie T, Cooper J D., Patterson G A. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg 2000 120 99-107
19. Charman S C., Sharples L D., McNeil K D., Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002 21 226-232
20. Meyer D M., Edwards L B., Torres F, Jessen M E., Novick R J. Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg 2005 79 950-957, discussion 957958
21. Nwakanma L U., Simpkins C E., Williams J A. et al. Impact of bilateral versus single lung transplantation on survival in recipients 60 years of age and older: analysis of United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2007 133 541-547
22. Keating D, Levvey B, Kotsimbos T et al. Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years. Transplant Proc 2009 41 289-291
23. Weiss E S., Allen J G., Merlo C A., Conte J V., Shah A S. Survival after single versus bilateral lung transplantation for high-risk patients with pulmonary fibrosis. Ann Thorac Surg 2009 88 1616-1625 discussion 1625-1626
24. Lettieri C J., Nathan S D., Barnett S D., Ahmad S, Shorr A F. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006 129 746-752
25. Arcasoy S M., Christie J D., Ferrari V A. et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003 167 735-740
26. Nadrous H F., Pellikka P A., Krowka M J. et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005 128 2393-2399
27. Zisman D A., Lynch J P. III, Strieter R M. et al. Pulmonary arterial hypertension (PAH) is common in patients with idiopathic pulmonary fibrosis referred for lung transplantation [abstract]. Am J Respir Crit Care Med 2005 2 A123
28. Gagermeier J, Dauber J H., Gibson K, Richards T, Kaminski N. Prevalence of secondary pulmonary hypertension in patients with idiopathic pulmonary fibrosis [abstract]. Proc Am Thorac Soc 2005 2 A205
29. Weitzenblum E, Ehrhart M, Rasaholinjanahary J, Hirth C. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration 1983 44 118-127
30. Shorr A F., Cors C, Lettieri C J., Nathan S. Pulmonary hypertension in idiopathic pulmonary fibrosis: epidemiology and clinical correlates. Chest 2005 128S 218S
31. Kawut S M., O'Shea M K., Bartels M N., Wilt J S., Sonett J R., Arcasoy S M. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 2005 99 1431-1439
32. Lederer D J., Caplan-Shaw C E., O'Shea M K. et al. Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. Am J Transplant 2006 6 398-403
33. Hamada K, Nagai S, Tanaka S et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007 131 (3) 650-656
34. King T E. Jr, Tooze J A., Schwarz M I., Brown K R., Cherniack R M. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001 164 (7) 1171-1181
35. Whelan T P., Dunitz J M., Kelly R F. et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant 2005 24 1269-1274
36. Whitson B A., Nath D S., Johnson A C. et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006 131 73-80
37. Bando K, Keenan R J., Paradis I L. et al. Impact of pulmonary hypertension on outcome after single-lung transplantation. Ann Thorac Surg 1994 58 1336-1342
38. Daud S A., Yusen R D., Meyers B F. et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007 175 507-513
39. Arcasoy S M., Fisher A, Hachem R R., Scavuzzo M, Ware L B., ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, V: Predictors and outcomes. J Heart Lung Transplant 2005 24 1483-1488
40. Kozower B D., Meyers B F., Smith M A. et al. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg 2008 135 166-171
41. Meyer D M., Bennett L E., Novick R J., Hosenpud J D. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. Chest 2000 118 1255-1262
42. de Perrot M, Bonser R S., Dark J et al, ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, III: Donor-related risk factors and markers. J Heart Lung Transplant 2005 24 1460-1467 (Pubitemid 41396440)
43. Lee J, Kuntz C L., Hadjiliadis D et al. Risk factors for primary graft dysfunction after lung transplantation [abstract]. Am J Respir Crit Care Med 2008 177 A396
44. Fiser S M., Kron I L., McLendon Long S, Kaza A K., Kern J A., Tribble C G. Early intervention after severe oxygenation index elevation improves survival following lung transplantation. J Heart Lung Transplant 2001 20 631-636
45. Barr M L., Kawut S M., Whelan T P. et al, ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, IV: Recipient-related risk factors and markers. J Heart Lung Transplant 2005 24 1468-1482
46. Bobadilla J L., Love R B., Jankowska-Gan E et al. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 2008 177 660-668
47. Nathan S D., Barnett S D., Urban B A., Nowalk C, Moran B R., Burton N. Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients. Chest 2003 123 1758-1763
48. Kelly K, Hertz M I. Obliterative bronchiolitis. Clin Chest Med 1997 18 319-338
49. Stewart S, Fishbein M C., Snell G I. et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007 26 1229-1242 (Pubitemid 350256994)
50. Estenne M, Maurer J R., Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002 21 297-310
51. Burton C M., Carlsen J, Mortensen J, Andersen C B., Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007 26 681-686
52. El-Gamel A, Awad M R., Hasleton P S. et al. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant 1999 18 517-523
53. El-Gamel A, Sim E, Hasleton P et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999 18 828-837
54. Snyder L D., Hartwig M G., Ganous T et al. Cytokine gene polymorphisms are not associated with bronchiolitis obliterans syndrome or survival after lung transplant. J Heart Lung Transplant 2006 25 1330-1335
55. Hodge S, Holmes M, Banerjee B et al. Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition. Am J Transplant 2009 9 727-733